ge healthcare (nyse: ge) provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. while we encourage and welcome comments to our linkedin page, these posts from members of the public do not necessarily represent ge healthcare views, and we do not confirm their accuracy or endorse them. ge healthcare is part of highly regulated medical device and pharmaceutical industry. posts and conversations may be removed as a result, but may be forwarded to other people within ge healthcare for follow-up as appropriate. as part of our commitment to you and to the rest of the linkedin members, we will do our best to ensure that the content on the page remains positive. however, since we cannot monitor every post or conversation feed, we realize that the occasional objectionable posts will pop up just from time to time. therefore, the company reserves the right to remove any postings at i
Company profile
Ticker
GEHC
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
GE Healthcare Holding LLC
SEC CIK
Corporate docs
Subsidiaries
Beijing GE Hualun Medical Equipment Company Limited • BK Medical ApS • BK Medical Australia Pty Ltd. • BK Medical Austria GmbH • BK Medical Benelux NV • BK Medical France SAS • BK Medical Holding Company, Inc. • BK Medical Italia S.r.l. • bk medical Medizinische Systeme GmbH • BK Medical Schweiz GmbH ...
IRS number
882515116
GEHC stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
15 Apr 24
ARS
2023 FY
Annual report to shareholders
4 Apr 24
DEFA14A
Additional proxy soliciting materials
4 Apr 24
DEF 14A
Definitive proxy
4 Apr 24
8-K
Prices Upsized Secondary Offering of 14,000,000 Shares
14 Mar 24
424B3
Prospectus supplement
14 Mar 24
FWP
Free writing prospectus
12 Mar 24
8-K
GE HealthCare Technologies Inc. Commences Secondary Offering of 13,000,000 Shares
16 Feb 24
424B4
Prospectus supplement with pricing info
16 Feb 24
424B3
Prospectus supplement
15 Feb 24
Latest ownership filings
4
Roland Rott
2 Apr 24
SC 13G/A
GENERAL ELECTRIC CO
2 Apr 24
4
Change in insider ownership
15 Mar 24
SC 13G/A
VANGUARD GROUP INC
11 Mar 24
4
Thomas J. Westrick
5 Mar 24
4
Kenneth R. Stacherski
5 Mar 24
4
JAMES SACCARO
5 Mar 24
4
Roland Rott
5 Mar 24
4
Kevin Michael O'Neill
5 Mar 24
4
George A. Newcomb
5 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Institutional ownership, Q4 2023
66.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 937 |
Opened positions | 116 |
Closed positions | 241 |
Increased positions | 328 |
Reduced positions | 335 |
13F shares | Current |
---|---|
Total value | 22.26 tn |
Total shares | 305.43 mm |
Total puts | 79.51 k |
Total calls | 60.24 k |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
GE GE Aerospace | 61.58 mm | $4.76 tn |
Capital Research Global Investors | 51.34 mm | $3.97 tn |
Vanguard | 44.41 mm | $3.43 tn |
STT State Street | 18.58 mm | $1.44 tn |
Dodge & Cox | 16.98 mm | $1.31 tn |
T. Rowe Price | 12.09 mm | $935.10 mm |
Hotchkis & Wiley Capital Management | 5.51 mm | $426.19 bn |
IVZ Invesco | 5.39 mm | $416.86 bn |
MS Morgan Stanley | 5.01 mm | $387.54 bn |
Newport Trust | 4.36 mm | $337.15 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | Roland Rott | Common Stock, par value $0.01 per share | Payment of exercise | Dispose F | No | No | 90.91 | 837 | 76.09 k | 23,829 |
15 Mar 24 | GE Aerospace | Common stock, par value $0.01 per share | Other | Dispose J | No | No | 0 | 14,000,000 | 0.00 | 32,631,302 |
1 Mar 24 | Thomas J. Westrick | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 2,965 | 0.00 | 20,259 |
1 Mar 24 | Thomas J. Westrick | Common Stock, par value $0.01 per share | Payment of exercise | Dispose F | No | No | 91.28 | 2,121 | 193.60 k | 17,294 |
1 Mar 24 | Thomas J. Westrick | Common Stock, par value $0.01 per share | Payment of exercise | Dispose F | No | No | 91.28 | 1,169 | 106.71 k | 19,415 |
1 Mar 24 | Thomas J. Westrick | Common Stock, par value $0.01 per share | Payment of exercise | Dispose F | No | No | 91.28 | 1,285 | 117.29 k | 20,584 |
1 Mar 24 | Thomas J. Westrick | Common Stock, par value $0.01 per share | Payment of exercise | Dispose F | No | No | 91.28 | 1,195 | 109.08 k | 21,869 |
1 Mar 24 | Thomas J. Westrick | Employee Stock Option Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 92.72 | 8,435 | 782.09 k | 8,435 |
1 Mar 24 | Kenneth R. Stacherski | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 4,718 | 0.00 | 57,549 |
1 Mar 24 | Kenneth R. Stacherski | Employee Stock Option Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 92.72 | 13,420 | 1.24 mm | 13,420 |
News
Why Is GE Aerospace Stock Trading Higher Today?
23 Apr 24
Elekta And GE Healthcare's MiM Software Announced Collaboration To Deliver Leading Cancer Treatment Planning Solutions
22 Apr 24
Mizuho Maintains Buy on GE HealthCare Techs, Raises Price Target to $110
11 Apr 24
Evercore ISI Group Maintains Outperform on GE HealthCare Techs, Raises Price Target to $100
4 Apr 24
Beyond The Numbers: 6 Analysts Discuss GE HealthCare Techs Stock
3 Apr 24
Press releases
GE HealthCare's MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes
22 Apr 24
GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women's Health Imaging
18 Apr 24
Treatment AI (CSE: TRUE) Unveils New AI-Powered Solutions Revolutionizing Medical Education
18 Apr 24
RSNA and GE HealthCare Bring Advanced Mammography Technology to Tanzania to Improve Access and Help Address Breast Cancer Mortality Rate
16 Apr 24
Unleashing AI in Healthcare: The Game-Changing Partnership Between Treatment AI (CSE: TRUE) and aiXplain concurrent with Federal Momentum
16 Apr 24